TRI Pollution Prevention Report for VERANOVA L.P. and Toluene

Facility ID: 01432PHRMC25PAT

Facility Name and Address:
VERANOVA L.P.
25 PATTON RD
DEVENS, MA 01434

Parent Company: VERANOVA BIDCO L.P.

Industry: Pharmaceutical Preparation Manufacturing (325412)
Chemical: Toluene

Production Related Waste Management for Selected Chemical


lchemid=0000108883
    Waste Management Comparison - 2021



Pollution Prevention Activities for Selected Chemical


Reporting Year Section 8.10: Newly Implemented Source Reduction Activity Section 8.10: Methods to Identify Activity Section 8.11: Optional Pollution Prevention Information*
2019 Barriers: B3-Barriers to P2 B3 - Concern that product quality may decline as a result of source reduction.

Barriers to P2: B3 - Concern that product quality may decline as a result of source reduction. - JM IS A CONTRACT PHARMACEUTICAL MANUFACTURING AND RESEARCH FIRM WHICH MANUFACTURES PRODUCTS ON A BATCH BASIS BY CLIENT. THE CLIENTS PROJECTS DICTATE THE CHEMICALS USED AND THE QUANTITIES. AS THESE PRODUCTS MAY BE IN FDA APPROVAL PROCESS OR ALREADY FDA APPROVED JM HAS LITTLE OPPORTUNITY TO ENCOURAGE LESS HAZARDOUS CHEMICAL SUBSTITUTIONS. WHEN POSSIBLE IN EARLY STAGES OF WORKING WITH NEW CLIENT, JM WILL OFFER TO OPTIMIZE PROCESS WHICHMAY RESULT IN LESS CHEMICALS USED OVERALL BY REDUCING NUMBER OF FILTRATIONS, WASHES, ETC.

2018 Barriers: B3-Barriers to P2 B3 - Concern that product quality may decline as a result of source reduction.

Barriers to P2: B3 - Concern that product quality may decline as a result of source reduction. - JM IS A CONTRACT PHARMACEUTICAL MANUFACTURING AND RESEARCH FIRM WHICH MANUFACTURES PRODUCTS ON A BATCH BASISBY CLIENT. THE CLIENTS PROJECTS DICTATE THE CHEMICALS USED AND THE QUANTITIES. AS THESE PRODUCTS MAY BE IN FDAAPPROVAL PROCESS OR ALREADY FDA APPROVED JM HAS LITTLE OPPORTUNITY TO ENCOURAGE LESS HAZARDOUS CHEMICALSUBSTITUTIONS. WHEN POSSIBLE IN EARLY STAGES OF WORKING WITH NEW CLIENT, JM WILL OFFER TO OPTIMIZE PROCESS WHICHMAY RESULT IN LESS CHEMICALS USED OVERALL BY REDUCING NUMBER OF FILTRATIONS, WASHES, ETC.

2017 Other Barriers to Source Reduction - JM IS A CONTRACT PHARMACEUTICAL MANUFACTURING AND RESEARCH FIRM WHICH MANUFACTURES PRODUCTS ON A BATCH BASIS BY CLIENT. THE CLIENTS PROJECTS DICTATE THE CHEMICALS USED AND THE QUANTITIES. AS THESE PRODUCTS MAY BE IN FDA APPROVAL PROCESS OR ALREADY FDA APPROVED JM HAS LITTLE OPPORTUNITY TO ENCOURAGE LESS HAZARDOUS CHEMICAL SUBSTITUTIONS. WHEN POSSIBLE IN EARLY STAGES OF WORKING WITH NEW CLIENT, JM WILL OFFER TO OPTIMIZE PROCESS WHICH MAY RESULT IN LESS CHEMICALS USED OVERALL BY REDUCING NUMBER OF FILTRATIONS, WASHES, ETC.


Other Environmental Practices: Energy Recovery - JM waste vendors seek opportunities to dispose of hazardous waste through energy recovery options whenever possible.

2016 Barriers: B3-Barriers to P2 B3 - Concern that product quality may decline as a result of source reduction.

Barriers to P2: B3 - Concern that product quality may decline as a result of source reduction. - JM is a pharmaceutical contract manufacturing company which manufactures active pharmaceutical ingredients and intermediates for clients. Chemical usage is dependent upon the clients' project requirements and whether the API or intermediate is in the FDA phase approval process. Once a compound is in the FDA approval process, changes to chemicals are often disapproved by clients. Projects are completed in a batch process model and each client's project may require different chemicals and different amounts of chemicals.

2014 Other Barriers to Source Reduction - The batch process and client project needs determine the chemcials used and the amounts.

2013 Source Reduction:: W58: Other process modifications
Methods to Identify SR Opportunities: T11: Other
W58: The operations team will review the processes to determine where there are opportunities to reduce or reuse solvents.

Source Reduction - The processes are reviewed to determine if the distillates can be reused to further process materials or if the distillates can be used for cleaning. This reduces the need for virgin solvent. Whether this can be done is contingent upon the processes and if the client permits this activity.
*Classifications of Optional Pollution Prevention Information shown in brackets are provided by EPA.


TRI Pollution Prevention Glossary

The Waste Management Hierarchy

The waste management hierarchy established by the Pollution Prevention Act (PPA) guides waste generators toward the best options for managing wastes. The preferred option is to prevent pollution at its source, but for waste that is generated, the preferred management methods are recycling, followed by burning for energy recovery, treatment and, as a last resort, disposing of the waste.
  • Source Reduction includes activities that eliminate or reduce the generation of chemical waste.
  • Recycling includes the recovery of a toxic chemical in waste for reuse.
  • Energy Recovery includes the combustion of toxic chemicals in waste to generate heat or electricity.
  • Treatment includes the destruction of a toxic chemical in waste.
  • Disposal or Other Releases includes toxic chemical quantities entering the environment.
The PPA requires facilities to provide the following details about each chemical they report to TRI:
Facilities may also provide optional Pollution Prevention Information describing their source reduction, recycling, or pollution control activities.